Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Streptococcus pneumoniae | 21 | 2024 | 730 | 4.780 |
Why?
|
DNA Transposable Elements | 12 | 2024 | 755 | 4.110 |
Why?
|
Genome, Bacterial | 6 | 2024 | 783 | 2.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 9 | 2020 | 3639 | 1.690 |
Why?
|
Acinetobacter baumannii | 9 | 2024 | 118 | 1.450 |
Why?
|
Gene Expression Regulation, Bacterial | 7 | 2024 | 1133 | 1.160 |
Why?
|
Sequence Analysis, DNA | 7 | 2020 | 4740 | 1.130 |
Why?
|
Drug Resistance, Bacterial | 7 | 2024 | 1048 | 1.100 |
Why?
|
Mutagenesis, Insertional | 4 | 2019 | 656 | 1.090 |
Why?
|
Anti-Bacterial Agents | 19 | 2024 | 7407 | 1.070 |
Why?
|
Genes, Essential | 2 | 2024 | 185 | 1.040 |
Why?
|
Genes, Bacterial | 5 | 2024 | 1073 | 1.010 |
Why?
|
Directed Molecular Evolution | 2 | 2024 | 162 | 0.870 |
Why?
|
DNA, Bacterial | 5 | 2020 | 1479 | 0.740 |
Why?
|
Gene Regulatory Networks | 3 | 2024 | 1745 | 0.730 |
Why?
|
Pneumococcal Infections | 6 | 2024 | 501 | 0.720 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2021 | 130 | 0.700 |
Why?
|
Virulence | 5 | 2024 | 1303 | 0.680 |
Why?
|
Bacterial Proteins | 11 | 2024 | 3847 | 0.630 |
Why?
|
Bacteria | 5 | 2020 | 2199 | 0.600 |
Why?
|
Acinetobacter Infections | 3 | 2024 | 73 | 0.600 |
Why?
|
Genes | 1 | 2020 | 1823 | 0.540 |
Why?
|
Daptomycin | 1 | 2016 | 71 | 0.530 |
Why?
|
Stress, Physiological | 2 | 2020 | 1403 | 0.510 |
Why?
|
Genetics, Microbial | 1 | 2015 | 53 | 0.490 |
Why?
|
Software | 2 | 2020 | 4434 | 0.470 |
Why?
|
Mutagenesis | 5 | 2024 | 1232 | 0.430 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2019 | 803 | 0.430 |
Why?
|
Graphite | 2 | 2024 | 78 | 0.410 |
Why?
|
Colistin | 2 | 2024 | 44 | 0.410 |
Why?
|
Amino Acyl-tRNA Synthetases | 2 | 2024 | 88 | 0.410 |
Why?
|
Molecular Sequence Annotation | 1 | 2015 | 522 | 0.410 |
Why?
|
HIV-1 | 6 | 2007 | 6863 | 0.390 |
Why?
|
Yersinia pseudotuberculosis | 2 | 2022 | 25 | 0.380 |
Why?
|
Drug Resistance, Multiple, Bacterial | 4 | 2024 | 587 | 0.380 |
Why?
|
Transcription, Genetic | 4 | 2018 | 7594 | 0.370 |
Why?
|
Molecular Biology | 1 | 2015 | 576 | 0.370 |
Why?
|
HIV Long Terminal Repeat | 3 | 2007 | 85 | 0.360 |
Why?
|
Pseudomonas aeruginosa | 1 | 2017 | 1277 | 0.330 |
Why?
|
Nasopharynx | 1 | 2012 | 401 | 0.330 |
Why?
|
Virus Replication | 4 | 2019 | 2435 | 0.330 |
Why?
|
Single-Cell Analysis | 2 | 2020 | 2449 | 0.330 |
Why?
|
Gene Expression Profiling | 4 | 2020 | 9420 | 0.320 |
Why?
|
Microbial Sensitivity Tests | 7 | 2024 | 1937 | 0.310 |
Why?
|
Bacteriophages | 2 | 2023 | 378 | 0.310 |
Why?
|
Genetic Fitness | 2 | 2021 | 115 | 0.310 |
Why?
|
Amino Acids | 2 | 2024 | 1718 | 0.300 |
Why?
|
Proteomics | 2 | 2022 | 3849 | 0.280 |
Why?
|
RNA, Transfer | 3 | 2024 | 292 | 0.270 |
Why?
|
Biosensing Techniques | 2 | 2024 | 650 | 0.260 |
Why?
|
Genomics | 3 | 2020 | 5821 | 0.260 |
Why?
|
Host-Parasite Interactions | 2 | 2007 | 300 | 0.250 |
Why?
|
Host-Pathogen Interactions | 4 | 2021 | 1459 | 0.240 |
Why?
|
Genome, Viral | 2 | 2023 | 667 | 0.240 |
Why?
|
Chromosome Mapping | 2 | 2012 | 4615 | 0.240 |
Why?
|
Response Elements | 1 | 2006 | 309 | 0.240 |
Why?
|
TATA Box | 1 | 2004 | 127 | 0.230 |
Why?
|
Diclofenac | 1 | 2024 | 68 | 0.230 |
Why?
|
Gene Library | 2 | 2019 | 1059 | 0.230 |
Why?
|
Wolbachia | 2 | 2003 | 21 | 0.220 |
Why?
|
Yersinia pestis | 1 | 2023 | 33 | 0.220 |
Why?
|
Plague | 1 | 2023 | 20 | 0.220 |
Why?
|
Mites | 2 | 2000 | 46 | 0.220 |
Why?
|
Gene Knockout Techniques | 2 | 2024 | 802 | 0.210 |
Why?
|
Fluoroquinolones | 1 | 2024 | 307 | 0.190 |
Why?
|
Symbiosis | 2 | 2003 | 294 | 0.180 |
Why?
|
Drug Tolerance | 1 | 2022 | 367 | 0.180 |
Why?
|
Transistors, Electronic | 1 | 2020 | 22 | 0.180 |
Why?
|
Microbial Interactions | 1 | 2020 | 74 | 0.170 |
Why?
|
Entropy | 1 | 2020 | 210 | 0.170 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2020 | 119 | 0.170 |
Why?
|
Prophages | 1 | 2019 | 39 | 0.170 |
Why?
|
Proteome | 1 | 2009 | 1862 | 0.170 |
Why?
|
Models, Genetic | 1 | 2009 | 3442 | 0.160 |
Why?
|
Virulence Factors | 2 | 2022 | 513 | 0.160 |
Why?
|
Drug Resistance, Microbial | 1 | 2022 | 825 | 0.160 |
Why?
|
Mutation | 8 | 2022 | 30052 | 0.150 |
Why?
|
Operon | 1 | 2018 | 372 | 0.150 |
Why?
|
Pneumococcal Vaccines | 2 | 2019 | 397 | 0.150 |
Why?
|
Evolution, Molecular | 1 | 2006 | 1886 | 0.150 |
Why?
|
Influenza A virus | 1 | 2021 | 458 | 0.150 |
Why?
|
Ciprofloxacin | 1 | 2019 | 312 | 0.140 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2020 | 432 | 0.130 |
Why?
|
Animals | 17 | 2024 | 168459 | 0.130 |
Why?
|
Metabolic Networks and Pathways | 1 | 2020 | 789 | 0.120 |
Why?
|
Culture Media | 1 | 2017 | 897 | 0.120 |
Why?
|
Molecular Chaperones | 1 | 2020 | 754 | 0.120 |
Why?
|
Escherichia coli | 2 | 2024 | 4217 | 0.120 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2020 | 0.120 |
Why?
|
Phenotype | 5 | 2024 | 16591 | 0.110 |
Why?
|
Mice | 12 | 2024 | 81525 | 0.110 |
Why?
|
RNA | 1 | 2024 | 2726 | 0.110 |
Why?
|
Promoter Regions, Genetic | 2 | 2004 | 5789 | 0.110 |
Why?
|
Staphylococcus aureus | 2 | 2020 | 1458 | 0.110 |
Why?
|
Norfloxacin | 1 | 2012 | 24 | 0.100 |
Why?
|
Cell Line | 5 | 2007 | 15601 | 0.100 |
Why?
|
Communicable Diseases | 1 | 2020 | 875 | 0.100 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2019 | 1351 | 0.100 |
Why?
|
RNA, Small Untranslated | 1 | 2012 | 77 | 0.100 |
Why?
|
Nitric Oxide | 1 | 2020 | 2135 | 0.090 |
Why?
|
Cross Infection | 1 | 2020 | 1422 | 0.090 |
Why?
|
Selection, Genetic | 2 | 2006 | 868 | 0.090 |
Why?
|
Sex Ratio | 2 | 2003 | 108 | 0.090 |
Why?
|
HIV Infections | 3 | 2007 | 17351 | 0.090 |
Why?
|
RNA, Bacterial | 1 | 2012 | 393 | 0.090 |
Why?
|
Humans | 24 | 2024 | 761504 | 0.090 |
Why?
|
Influenza, Human | 1 | 2021 | 1521 | 0.090 |
Why?
|
Peptides | 2 | 2020 | 4358 | 0.080 |
Why?
|
Genotype | 3 | 2012 | 12990 | 0.080 |
Why?
|
Drug Synergism | 2 | 2024 | 1755 | 0.080 |
Why?
|
DNA Damage | 2 | 2019 | 2446 | 0.070 |
Why?
|
Acclimatization | 1 | 2007 | 113 | 0.070 |
Why?
|
Signal Transduction | 1 | 2009 | 23445 | 0.070 |
Why?
|
Anemia, Sickle Cell | 1 | 2014 | 1063 | 0.060 |
Why?
|
Macrophages | 1 | 2020 | 5769 | 0.060 |
Why?
|
Leucine-tRNA Ligase | 1 | 2024 | 4 | 0.060 |
Why?
|
Adaptation, Biological | 1 | 2005 | 147 | 0.060 |
Why?
|
Phylogeny | 3 | 2024 | 2811 | 0.060 |
Why?
|
Biological Evolution | 2 | 2007 | 1071 | 0.060 |
Why?
|
Tetranychidae | 1 | 2003 | 3 | 0.050 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2024 | 168 | 0.050 |
Why?
|
Sigma Factor | 1 | 2024 | 176 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12690 | 0.050 |
Why?
|
beta-Lactam Resistance | 1 | 2022 | 73 | 0.050 |
Why?
|
Phenylacetates | 1 | 2022 | 112 | 0.050 |
Why?
|
Streptolysins | 1 | 2022 | 57 | 0.050 |
Why?
|
Gene Transfer, Horizontal | 1 | 2022 | 145 | 0.050 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2022 | 53 | 0.050 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2004 | 439 | 0.050 |
Why?
|
Penicillin-Binding Proteins | 1 | 2022 | 148 | 0.050 |
Why?
|
Materials Testing | 1 | 2024 | 863 | 0.050 |
Why?
|
Doxycycline | 1 | 2022 | 344 | 0.040 |
Why?
|
Permeability | 1 | 2022 | 723 | 0.040 |
Why?
|
RNA Polymerase II | 1 | 2004 | 539 | 0.040 |
Why?
|
Bacterial Capsules | 1 | 2021 | 244 | 0.040 |
Why?
|
Particle Size | 1 | 2024 | 1648 | 0.040 |
Why?
|
DNA Fingerprinting | 1 | 2000 | 114 | 0.040 |
Why?
|
DNA Topoisomerase IV | 1 | 2019 | 42 | 0.040 |
Why?
|
Electrodes | 1 | 2022 | 614 | 0.040 |
Why?
|
Phenols | 1 | 2023 | 517 | 0.040 |
Why?
|
Organ Specificity | 1 | 2004 | 1967 | 0.040 |
Why?
|
Metals | 1 | 2023 | 719 | 0.040 |
Why?
|
DNA Gyrase | 1 | 2019 | 85 | 0.040 |
Why?
|
Boranes | 1 | 2018 | 1 | 0.040 |
Why?
|
Ferrets | 1 | 2019 | 177 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2022 | 730 | 0.040 |
Why?
|
Polymorphism, Genetic | 2 | 2007 | 4243 | 0.040 |
Why?
|
Crosses, Genetic | 1 | 1999 | 749 | 0.040 |
Why?
|
Base Sequence | 2 | 2012 | 12441 | 0.040 |
Why?
|
Reproduction | 1 | 2003 | 645 | 0.040 |
Why?
|
Mammals | 1 | 2024 | 1132 | 0.040 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2007 | 2199 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2004 | 1363 | 0.040 |
Why?
|
Biofilms | 1 | 2022 | 628 | 0.040 |
Why?
|
Cell Wall | 1 | 2020 | 425 | 0.040 |
Why?
|
Thermodynamics | 1 | 2018 | 595 | 0.030 |
Why?
|
Molecular Probes | 1 | 2018 | 309 | 0.030 |
Why?
|
Vaccines, Synthetic | 1 | 2019 | 616 | 0.030 |
Why?
|
Cell Division | 1 | 2004 | 4465 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 1612 | 0.030 |
Why?
|
Kinetics | 1 | 2004 | 6374 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2024 | 1685 | 0.030 |
Why?
|
Treatment Failure | 1 | 2022 | 2645 | 0.030 |
Why?
|
Thiazoles | 1 | 2023 | 1517 | 0.030 |
Why?
|
Computer Simulation | 1 | 2009 | 6240 | 0.030 |
Why?
|
NF-kappa B | 1 | 2004 | 2490 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2024 | 4278 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 2273 | 0.030 |
Why?
|
Binding Sites | 2 | 2018 | 6055 | 0.030 |
Why?
|
Boronic Acids | 1 | 2018 | 915 | 0.030 |
Why?
|
Time Factors | 2 | 2007 | 39967 | 0.030 |
Why?
|
Molecular Structure | 1 | 2018 | 1880 | 0.030 |
Why?
|
Genetic Variation | 2 | 2007 | 6567 | 0.030 |
Why?
|
Social Behavior | 1 | 2020 | 1135 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2004 | 5486 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 934 | 0.030 |
Why?
|
Leukocytes | 1 | 2021 | 2026 | 0.030 |
Why?
|
Hot Temperature | 1 | 1999 | 1440 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18252 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1886 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4111 | 0.020 |
Why?
|
Equipment Design | 1 | 2020 | 3510 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2020 | 1390 | 0.020 |
Why?
|
Administration, Oral | 1 | 1999 | 4021 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2022 | 3113 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1999 | 6075 | 0.020 |
Why?
|
Disease Progression | 1 | 2007 | 13506 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2004 | 5796 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2007 | 10194 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2012 | 902 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6863 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2014 | 1301 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 9606 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7396 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3537 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3808 | 0.020 |
Why?
|
Transcription Factors | 1 | 2004 | 12128 | 0.010 |
Why?
|
Terminal Repeat Sequences | 1 | 2004 | 70 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9469 | 0.010 |
Why?
|
Hybridomas | 1 | 2004 | 442 | 0.010 |
Why?
|
Litter Size | 1 | 2003 | 49 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2004 | 1141 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2004 | 740 | 0.010 |
Why?
|
Luciferases | 1 | 2004 | 714 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2004 | 389 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17635 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2004 | 1529 | 0.010 |
Why?
|
Cytoplasm | 1 | 2004 | 1510 | 0.010 |
Why?
|
Plasmids | 1 | 2004 | 2269 | 0.010 |
Why?
|
Human Genome Project | 1 | 2000 | 200 | 0.010 |
Why?
|
Quantitative Trait, Heritable | 1 | 2000 | 543 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5774 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2004 | 2909 | 0.010 |
Why?
|
Species Specificity | 1 | 2000 | 2414 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2004 | 3395 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 9351 | 0.010 |
Why?
|
Infant | 1 | 2014 | 36192 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2004 | 4369 | 0.010 |
Why?
|
Male | 3 | 2014 | 360804 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 42230 | 0.010 |
Why?
|
Female | 3 | 2014 | 392644 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 54425 | 0.010 |
Why?
|
Child | 1 | 2014 | 80153 | 0.000 |
Why?
|
Adolescent | 1 | 2014 | 88319 | 0.000 |
Why?
|
Concepts
(224)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_